GovChime
Notice ID: 9c61d7b197bf2c2932dd4324a65772c3Solicitation

Reagents

Archived on September 20, 2013. Original response deadline: . The description is published on SAM.gov: Full description on SAM.gov.

Overview

Response deadline
6:59 AM UTC+02:00
Posted
August 23, 2013
Notice type
Solicitation
NAICS
621511: Medical Laboratories

Notice details

Place of performance
Geilenkirchen Air Base
PSC
Q: MEDICAL SERVICES
Last updated
Dec 3, 2025

Identifiers

Solicitation number
FA560613T0058
Notice ID
9c61d7b197bf2c2932dd4324a65772c3

Description

No description in the SAM.gov data feed for this notice.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Claudia Mans
Fax: (49) 6565 61 9106

Documents

No documents available.

Lifecycle

Solicitation:FA560613T0058
  1. Pre-Solicitation
  2. Solicitation

Award typically follows within 30–90 days after the response deadline. (estimate)

  1. Pre-SolicitationAug 22, 2013

    Reagents

    Notice cc8a898a120b4fd24ae8c76c98c3c1b8 on SAM.gov

  2. SolicitationCurrentAug 23, 2013

    Reagents

    Notice 9c61d7b197bf2c2932dd4324a65772c3 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
This is a Sources Sought Notice only. It is issued solely for information and planning purposes and does not constitute a solicitation. This notice is issued in accordance with Federal Acquisition Regulation (FAR) Part 10, Market Research. The Department of Veterans Affairs (VA) is conducting market research to identify qualified sources capable of providing prostate cancer genomic classifier testing services. The purpose of this notice is to determine the availability of capable businesses and inform an appropriate acquisition strategy. This notice shall not be construed as a commitment by the Government to issue a solicitation or award a contract. Responses are not offers and cannot be accepted by the Government to form a binding contract. The Government will not reimburse any costs associated with responding to this notice. See attached document for details and response requirements.
55%
Market Research11/25/2026
The Department of Veterans Affairs, Nebraska-Western Iowa Health Care System , has a requirement for medical laboratory, pathology and testing analysis services. The Contractor shall be responsible for performing pre-analytic processing as defined in its laboratory manual, analysis, and reporting of analytical results and interpretation for clinical and anatomical pathology specimens as requested by participating facilities (listed below) during the contract period. The contractor shall provide Pathology and Laboratory Medicine Services, on a scheduled basis, in accordance with the specifications, terms and conditions herein. VA will be responsible for specimen collection, preparation, grossing (with the exception of, cytology specimens); global surgical pathology cases would require grossing by the contractor. The VA will accession histology and cytology cases, VistA accessioning, preservation and storage of final slides and blocks. All slides and blocks must be returned to the VA for permanent storage. NOTE: The Solicitation number in the announcement 36C26326R0063 was entered incorrectly, however, cannot be changed. The correct solicitation number is 36C26326Q0727. This number has been reconciled throughout the documents.
55%
Solicitation11/30/2026
The Department of Veterans Affairs, James A. Haley VA Medical Center s (JAHVAMC) intent to solicit sole source to Pacific Edge Diagnostics USA Ltd., for specialized reference laboratory services for Cxbladder molecular diagnostic testing. 1.OBJECTIVE: 1.1 JAHVAMC requires Cxbladder testing for patients with suspected urothelial carcinoma, a history of urothelial carcinoma, or urinary tract abnormalities that cannot be definitively classified by routine morphologic evaluation alone. Cxbladder testing evaluates urinary messenger RNA (mRNA) biomarkers associated with urothelial carcinoma and provides clinically relevant molecular information to support diagnostic clarification, risk stratification, surveillance, and informed treatment decisions. JAHVAMC seeks a firm fixed-price, cost-per-test contract consisting of one 12-month base period and four 12-month option periods. The Contractor shall furnish Cxbladder Triage® and Cxbladder Monitor® testing, including all required test kits, collection and shipping materials, specimen transportation, laboratory analysis, result reporting, technical support, and secure electronic access to finalized test results. 2. SCOPE: 2.1 The Contractor shall furnish all labor, materials, equipment, supplies, shipping services, technical expertise, reporting capabilities, and administrative support necessary to perform Cxbladder Triage and Cxbladder Monitor testing for JAHVAMC, located in Tampa, Florida. Cxbladder Triage and Cxbladder Monitor testing support the clinical evaluation and management of patients who may be at risk for urothelial carcinoma. 2.2 Cxbladder Triage assists clinicians in identifying patients who may require further diagnostic evaluation for urothelial carcinoma. The test supports risk assessment and may help reduce unnecessary invasive diagnostic procedures in patients with a low likelihood of malignancy. 2.3 Cxbladder Monitor supports surveillance of patients with a history of urothelial carcinoma by identifying molecular signals associated with possible recurrent or progressive disease. The test assists clinicians in determining the appropriate level and timing of follow-up evaluation. Determination by the Government not to compete this proposed contract based on responses to this notice is solely within the discretion of the Government. 2.4 Important information: The Government is not obligated to, nor will it pay for or reimburse any costs associated with responding to this Special Notice. This notice shall not be construed as a commitment by the Government to issue a solicitation or ultimately award a contract, nor does it restrict the Government to a particular acquisition approach. The Government will in no way be bound to this information if any solicitation is issued. No sub-contracting opportunity is anticipated. The North American Classification System (NAICS) code for this acquisition is 621511 Medical Laboratories with a size standard of $36.5 Million. Any offeror capable of providing this service shall notify the Contracting Officer by email within seven (7) calendar days from the date of the publication of this special notice. *Responses must include written documentation from the OEM, Pacific Edge Diagnostics USA Ltd., showing your company is an authorized service provider. All information is to be submitted no later than 2:00 PM EST, on Tuesday, November 23, 2026, to: keila.president@va.gov.
55%
Special Notice11/23/2026
55%
AwardedOpen
55%
Combined Synopsis11/18/2026

Additional Details

Solicitation Number

FA560613T0058

Archive Date

Sep 20, 2013